Simultaneous integrated boost
Showing 1 - 25 of 5,254
Soft Tissue Sarcoma Trial in Florence (RT)
Recruiting
- Soft Tissue Sarcoma
- RT
-
Florence, Fi, ItalyAOU Careggi
Feb 27, 2023
Carcinoma, Adenoid Cystic, Head Neck Cancer Trial in Pavia (simultaneous integrated boost of carbon ions radiation therapy)
Not yet recruiting
- Carcinoma, Adenoid Cystic
- Head and Neck Cancer
- simultaneous integrated boost of carbon ions radiation therapy
-
Pavia, ItalyCNAO
Feb 8, 2023
Breast Cancer, Radiotherapy Side Effect Trial in Beijing (Ultra-fractionated radiation therapy)
Recruiting
- Breast Cancer
- Radiotherapy Side Effect
- Ultra-fractionated radiation therapy
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Mar 9, 2023
Breast Cancer, Radiotherapy Side Effect Trial in Graz (Simultaneous integrated boost)
Withdrawn
- Breast Cancer
- Radiotherapy Side Effect
- Simultaneous integrated boost
-
Graz, AustriaMedical University of Graz
Oct 7, 2022
Glioblastoma Multiforme, Adult Trial (Integrated boost technique (SIB) guided by PET FDOPA)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Integrated boost technique (SIB) guided by PET FDOPA
- (no location specified)
Dec 7, 2022
Oligometastatic Disease Trial in Milan (radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost,
Recruiting
- Oligometastatic Disease
- radiosurgery and stereotactic ablative radiotherapy with simultaneous integrated boost, respectively
-
Milan, MI, ItalySan Raffaele Scientific Institute
Dec 23, 2022
Rectal Cancer by MRI-guided Radiotherapy
Not yet recruiting
- Rectal Cancer
- Radiotherapy with MRIdian with simultaneous integrated boost
- Questionnaires before, during and after radiotherapy
- (no location specified)
Jun 13, 2023
Glioblastoma Trial in Strasbourg (Simultaneous-integrated boost with IMRT)
Not yet recruiting
- Glioblastoma
- Simultaneous-integrated boost with IMRT
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Dec 7, 2022
Prostate Cancer, Cancer of the Prostate Trial in Saint Louis (device, radiation, drug)
Recruiting
- Prostate Cancer
- Cancer of the Prostate
- Ethos Varian treatment system
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)
Recruiting
- Rectal Neoplasms
- Tislelizumab
- +4 more
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 27, 2023
Breast Cancer, Surgery, Adjuvant Radiotherapy Trial in Beijing (Hypofractionation with simultaneous integrated boost)
Recruiting
- Breast Cancer
- +2 more
- Hypofractionation with simultaneous integrated boost
-
Beijing, ChinaBeijing Shijitan Hospital
Aug 25, 2021
Localized Prostate Cancer Trial in Shanghai (carbon ion irradation, Carbon Ion Irradiation With SIB)
Recruiting
- Localized Prostate Cancer
- carbon ion irradation
- Carbon Ion Irradiation With SIB
-
Shanghai, ChinaShanghai Proton and Heavy Ion Center
Nov 12, 2021
Larynx, Lip, Oral Cavity and Pharynx Trial in Philadelphia (Nivolumab, Ipilimumab, Simultaneous-Integrated Boost
Completed
- Larynx
- Lip, Oral Cavity and Pharynx
- Nivolumab
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
Brain Metastases Trial in Indianapolis (Cohort A, Cohort B)
Recruiting
- Brain Metastases
- Cohort A
- Cohort B
-
Indianapolis, Indiana
- +2 more
Feb 28, 2022
Solid Tumor Spine Metastases Trial in Dublin (Radiation: image guided dose escalated SABR using a simultaneous integrated boost
Not yet recruiting
- Solid Tumor Spine Metastases
- Radiation: image guided dose escalated SABR using a simultaneous integrated boost (SIB)
-
Dublin, Ireland
- +1 more
Oct 16, 2023
Pancreatic Cancer Non-resectable Trial in Shanghai (Carbon ion radiotherapy)
Not yet recruiting
- Pancreatic Cancer Non-resectable
- Carbon ion radiotherapy
-
Shanghai, ChinaShanghai Proton and Heavy Ion Center
Jun 22, 2022
Pancreatic Carcinoma Trial in Nanjing (Tislelizumab, Gemcitabine, Nab paclitaxel)
Recruiting
- Pancreatic Carcinoma
- Tislelizumab
- +3 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 1, 2022
Locally Advanced Cervical Carcinoma Trial (Hypofractionation)
Not yet recruiting
- Locally Advanced Cervical Carcinoma
- Hypofractionation
- (no location specified)
Jun 25, 2022
Breast Cancer Trial in Groningen (Simultaneous Integrated Boost Technique)
Recruiting
- Breast Cancer
- Simultaneous Integrated Boost Technique
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jun 24, 2021
Glioblastoma Multiforme, Adult, Glioblastoma, IDH-mutant Trial (Dose escalation + Reduced Margin Adaptive Radiotherapy)
Not yet recruiting
- Glioblastoma Multiforme, Adult
- Glioblastoma, IDH-mutant
- Dose escalation + Reduced Margin Adaptive Radiotherapy
- (no location specified)
Oct 3, 2022
Lymphedema, Fibrosis Trial in Aarhus (Loco-regional RT)
Active, not recruiting
- Lymphedema
- Fibrosis
- Loco-regional RT
-
Aarhus, DenmarkAarhus University Hospital
Jul 7, 2021
Non Small Cell Lung Cancer, Stage IV NSCLC, Brain Metastases Trial in Hangzhou (Hypofractionated Stereotactic Radiotherap)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Hypofractionated Stereotactic Radiotherap
-
Hangzhou, ChinaKaicheng Pan
Oct 18, 2022
Low or Intermediate Risk Prostate Cancer Trial in Detroit (MR guided Linear Accelerator)
Withdrawn
- Low or Intermediate Risk Prostate Cancer
- MR guided Linear Accelerator
-
Detroit, MichiganHenry Ford Health System
Feb 9, 2022
Brain Metastases Trial in Vancouver (whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric
Active, not recruiting
- Brain Metastases
- whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy
-
Vancouver, British Columbia, CanadaBC Cancer Agency - Vancouver Centre
Sep 17, 2021
Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost Trial in Germany
Completed
- Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost
- Hypofractionation with simultaneous integrated boost
-
Berlin, Germany
- +18 more
Aug 19, 2021